Uses
Although intended by Eli Lilly to be used as a nasal decongestant, methylhexaneamine has been marketed as a dietary supplement in combination with caffeine and other ingredients, under trade names such as Geranamine and Floradrene, to be used as an over-the-counter thermogenic or general-purpose stimulant. Methylhexaneamine has not been studied intensively and its pharmacological profile has not been evaluated since Eli Lilly filed its patent in 1944, stating that the stimulant effects on the CNS are less than that of the related compounds amphetamine and ephedrine.
In New Zealand, methylhexanamine (under the name 1,3-dimethylamylamine or DMAA) is an emerging active ingredient of party pills. In November 2009, the New Zealand government indicated methylhexanamine would be scheduled as a restricted substance. The New Zealand government has not banned methylhexanamine, but its Ministry of Health has banned bulk powder purchases, and its sale in the form of capsules and tablets is permitted. The NZ Ministry of Health has now published a Temporary Class Drug Notice. The effect of this notice is to make illegal the sale of DMAA products after 7 April 2012.
Read more about this topic: Methylhexanamine